Open Book Extracts

Activities: Ingredients

Trending Articles

  1. PureHealth Research targets two major age-related health concerns with solutions for hearing and circulation As awareness of preventive supplementation grows, PureHealth Research is addressing the biological mechanisms behind auditory decline and poor peripheral circulation with...
  2. Herbalife to acquire Bioniq to expand personalised nutrition capabilities Herbalife has agreed to acquire assets from UK-based Bioniq in a deal aimed at scaling data-driven personalised supplements globally, combining biomarker-based formulations...
  3. Clinically studied lymph system supplements show promise for improving fluid balance and reducing swelling PureHealth Research has launched lymphatic support supplements formulated with botanicals such as burdock root, echinacea and dandelion, backed by clinical research for their...
  4. Pendulum launches flavourless Gut Fuel prebiotic blend to support microbiome and GLP-1 signalling US gut health company Pendulum Therapeutics has introduced Gut Fuel, a doctor-formulated prebiotic fibre and polyphenol powder combining resistant potato starch, baobab,...
  5. European Patent Office invalidates key dsm-firmenich patent on high-potency microalgal DHA oils The EPO Appeal Board has ruled in favour of Mara Renewables, invalidating a dsm-firmenich patent relating to high-potency microalgal DHA oils following a two-day hearing,...

Upcoming event

Making Nutraceuticals

21–22 April 2026 | Conference/Exhibition | Coventry, UK See all

Related Content

Ingredients

Open Book Extracts (OBX) announces founding membership in ONE HEMP

Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients

OBX launches trial for minor cannabinoid formulations

The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance

OBX receives strategic investment from Btomorrow Ventures

The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients

Open Book Extracts expands capabilities and management team to boost finished goods manufacturing

The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory

OBX announces results of Phase I toxicology assessment

The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients

OBX completes trial of cannabinoids for pain relief

Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients

Open Book Extracts appoints European sales leadership

In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now